Innova Captab Q1 Results Net Income Rises to ₹29.48 Crores

Innova Captab Q1 Results: Innova Captab recently released its Q1 financial results for June 2024. The company reported a total revenue of ₹294.27 crores, which shows strong growth compared to ₹216.41 crores in March 2024 and ₹233.24 crores in June 2023. This increase in revenue indicates that the company is performing well and gaining more customers. Their selling, general, and administrative (SG&A) expenses totaled ₹24.88 crores, up from ₹13.29 crores in March and ₹14.89 crores a year ago. This increase suggests that the company is investing more in its operations, which can be a good sign for future growth.

Innova Captab’s total operating expenses were ₹256.95 crores, leading to an operating income of ₹37.32 crores, which is a significant increase from ₹17.03 crores in the previous quarter and ₹28.51 crores year-on-year. The net income before taxes also rose to ₹39.31 crores, compared to ₹15.36 crores last quarter and ₹24.60 crores last year. The net income for this quarter was ₹29.48 crores, showing growth from ₹13.07 crores in March and ₹17.59 crores a year ago. The diluted normalized earnings per share (EPS) was ₹5.15, up from ₹2.72 in the previous quarter and ₹3.67 in the same quarter last year.

Here are the quarterly financial results for Innova Captab for Q1, presented in a simple and clear format:

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Innova Captab Q1 Results

The Innova Captab table shows the financial performance of the company over different time periods. It includes important information about income, expenses, profit, and share capital. The table compares data for the quarter that ended on June 30, 2024, with the previous quarter (March 31, 2024) and the same quarter from the previous year (June 30, 2023).

Innova Captab’s revenue from operations for the latest quarter is ₹2,942.70 million, which is higher than the ₹2,332.43 million earned in the same quarter last year. This shows that the company is growing and making more money from its operations. However, the total expenses also increased to ₹2,570.86 million from ₹2,097.69 million in the same quarter last year. Despite higher expenses, the profit for the period reached ₹294.77 million, showing a significant increase from ₹175.93 million the previous year.

Here's a simplified summary of the unaudited consolidated financial results for the quarter and period ended June 30, 2024:

(in million INR)

Innova Captab Stock Metrics

The Innova Captab data table shows important financial information about the company. Its market cap is ₹ 4,176 crore, which indicates the total value of all its shares in the stock market. The current stock price is ₹ 730, and the price has reached a high of ₹ 842 and a low of ₹ 421 in the past. The Stock P/E ratio is 39.3, meaning investors are willing to pay ₹ 39.3 for every ₹ 1 of earnings. The book value is ₹ 145, showing the company's net worth per share. It has a dividend yield of 0.00%, meaning it doesn't pay dividends to shareholders. 

Here’s the information presented in a simple table format for clarity:

Quarterly Results 

The Innova Captab table shows the financial results for three quarters: December 2023, March 2024, and June 2024. In December 2023, sales were 302 crores, and expenses were 258 crores, resulting in an operating profit of 45 crores, which is a 15% profit margin. In March 2024, sales dropped to 263 crores, but expenses also decreased to 225 crores, leading to a higher profit before tax of 40 crores. Finally, in June 2024, sales increased to 294 crores, with expenses rising to 252 crores. 

Here’s the version of the quarterly results summary for December 2023, March 2024, and June 2024:

(Consolidated Figures in Rs. Crores)

About Innova Captab

Innova Captab is a well-known pharmaceutical company in India. Established in 2006, it focuses on various aspects of the pharmaceutical industry, including research, manufacturing, and distribution of medicines. The company has grown significantly over the years and serves many top Indian pharmaceutical firms. They operate two modern manufacturing facilities that meet international quality standards, ensuring safe and effective products. Innova Captab emphasizes research and development (R&D) to create a diverse range of medicines to meet customer needs.

With a dedicated team of over 1,000 employees, the company is committed to high-quality production and customer satisfaction. Innova Captab prioritizes Environmental, Social, and Governance (ESG) practices, ensuring compliance with legal standards, ethical conduct, and sustainability.